Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company, 37277 [2023-12127]
Download as PDF
<![CDATA[
37277
Federal Register / Vol. 88, No. 109 / Wednesday, June 7, 2023 / Notices
following basic class(es) of controlled
substance(s):
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Controlled substance
[Docket No. DEA–1214]
Importer of Controlled Substances
Application: Arizona Department of
Corrections
Pentobarbital ...................
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Arizona Department of
Corrections has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 7, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 7, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 5, 2023, Arizona
Department of Corrections, 1305 East
Butte Avenue, ASPC-Florence, Florence,
Arizona 85132–9221, applied to be
registered as an importer of the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:01 Jun 06, 2023
Jkt 259001
Drug
code
Schedule
2270
II
The facility intends to import the
above-listed controlled substance for
legitimate needs. This particular
controlled substance is not available for
the intended legitimate need within the
current domestic supply of the United
States. No other activities for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–12131 Filed 6–6–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1212]
Bulk Manufacturer of Controlled
Substances Application:
Biopharmaceutical Research Company
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on April 28, 2023,
Biopharmaceutical Research Company,
11045 Commercial Parkway, Castroville,
California 95012–3209, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Drug
code
Schedule
Marihuana Extract ............
Marihuana .........................
Tetrahydrocannabinols .....
7350
7360
7370
I
I
I
The company plans to bulk
manufacture the listed controlled
substances to provided Pharmaceuticalgrade marihuana in order to facilitate
research in a manner that complies with
local, state, and federal regulations. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–12127 Filed 6–6–23; 8:45 am]
BILLING CODE P
AGENCY:
DEPARTMENT OF JUSTICE
Biopharmaceutical Research
Company, has applied to be registered
as a bulk manufacturer of basic class(es)
of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 7, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 7, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–1210]
Bulk Manufacturer of Controlled
Substances Application: Bright Green
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Bright Green Corporation, has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 7, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 7, 2023.
SUMMARY:
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 88, Number 109 (Wednesday, June 7, 2023)]
[Notices]
[Page 37277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12127]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1212]
Bulk Manufacturer of Controlled Substances Application:
Biopharmaceutical Research Company
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Biopharmaceutical Research Company, has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 7, 2023. Such persons may also file a written request for a
hearing on the application on or before August 7, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 28, 2023, Biopharmaceutical Research Company,
11045 Commercial Parkway, Castroville, California 95012-3209, applied
to be registered as a bulk manufacturer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances to provided Pharmaceutical-grade marihuana in order to
facilitate research in a manner that complies with local, state, and
federal regulations. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-12127 Filed 6-6-23; 8:45 am]
BILLING CODE P
